O
Oxygenta Pharmaceutical
OXYGENTAPH Share Price
Healthcare51.25
as on 09 Mar 2026 at 10:44
BSE
Market Cap
₹190 Cr
PE Ratio
-10.40
ROCE
402.56%
OXYGENTAPH Fundamentals
Company Valuation
Market Cap (₹ Cr.)
190
PE Ratio
-10.40
PB Ratio
-5.10
Dividend Yield
-
ROE
38.69%
ROCE
402.56%
Book Value (₹)
-9.92
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 51.12% | 51.12% | 57.95% | 57.95% | 55.93% |
| Domestic Institutional Investors (DII) | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 43.93% | 43.93% | 36.61% | 36.55% | 38.90% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
OXYGENTAPH Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524636
NSE Scrip Name
OXYGENTAPH
ISIN
INE102E01018



